Skip to content
OpenCapital
Get started

LanzaTech Global, Inc. LNZA Concentration Risk %

Concentration Risk % at other companies

Identive logo
IdentiveINVE
10.3%+7.7pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
RF Industries logo
RF IndustriesRFIL
100%0.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp

Other financials

Income statement

See full
Revenue$12.0M+26.8%
Operating income-$9.8M+68.4%
Net income-$14.7M+23.7%
EPS (diluted)-$1.77+81.9%

Balance sheet

See full
Cash & equivalents$19.9M+23.9%
Total debt$16.3M-46.1%
Total equity$48.1M+4,194%
Total assets$105.2M-16.4%

Cash flow

See full
Operating cash flow-$9.3M+56.1%
CapEx$55.0K-92.3%
Free cash flow-$9.3M+57.3%

Valuation

See full
Market cap$75.63M-77.6%
Enterprise value$72.09M-77.0%
P/S1.3×-7.1×

Profitability

See full
Operating margin-99.2%-36.2pp
Net margin-76.1%-31.8pp
FCF margin-91.8%-29.8pp

Returns & leverage

See full
Return on equity-215.3%—
Debt / equity0.3×—
Current ratio2×-0.2×